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Effective crop protection depends on the quality of decision mak-
ing in response to the threat of plant disease in much the same way
that the quality of shared decision making by doctors and patients
contributes to effective healthcare. This article delves into the clinical
literature in order to provide a perspective on some recent discussions
of shared decision making presented there, discussions that relate to
issues also faced in sustainable crop protection. The aim in so doing
is to contribute an overview of the decision process, looking in par-
ticular for a way in which decision owners (usually, in the context of
crop protection at the field scale, the decision owners are the farmers)
may have an opportunity to express their decision preferences. In the
clinical situation, the diagnostic decision-making process involves
a dynamic exchange between doctor and patient. A starting point
is provided by Sbrojavacca (2012): “When, as it happens often, we
are in the grey zone of diagnostic uncertainty we use diagnostic tests
to seek to reach a decision threshold.” ... “Diagnostic tests are im-
perfect. In the grey area of diagnostic uncertainty they help us to
reach a certain critical threshold beyond which we must decide.”
From this perspective, diagnosis is more than identification. It is
the requirement for treatment that is diagnosed, the aim of treatment
being to prevent, or at least reduce, the extent of future adverse con-
sequences. The term diagnostic test may refer to any procedure that
provides evidence about factors related to those adverse conse-
quences. Although diagnostic tests are imperfect, the application of
diagnostic decision thresholds plays a fundamental part in the strategy
of preventive medicine (Rose et al. 2008). Sbrojavacca describes an
informal survey carried out among doctors taking part in training
courses with the aim of eliciting a brief operative description of diag-
nosis. At least in part, it is Sbrojavacca’s thought-provoking (and en-
tertaining) account of his colleagues’ survey responses that led us to
consider our own perspective on the diagnostic process in crop pro-
tection decision making.
Unlike some of the respondents to Sbrojavacca’s (2012) survey,
Vickers et al. (2008) have no trouble defining clinical diagnosis:
“The concept of diagnosis is essentially binary: you either have a cer-
tain disease or you do not.” The authors then use this definition to
draw attention to a problem they perceive that arises for diseases
characterized by a continuous range of severity: categorizing individ-
ual patients either as having or not having the disease depends on
a “somewhat arbitrary cut-point” of disease severity. Thus, from
the perspective of Vickers et al., thresholds are (at least in some
cases) regarded as an inadequate reflection of disease biology
and invariable to patient preference. For example, Vickers et al. de-
scribe the diagnostic approach to blood pressure as a division of the
population into two groups, those with hypertension and those
without hypertension, and then treatment of the former group but
not the latter. They propose instead that thinking about disease in
terms of risk prediction is often superior to thinking about disease
in terms of diagnosis. Here, risk refers to a probability associated
with adverse consequences. In both clinical medicine and crop pro-
tection, the goal of diagnostic decision making is to facilitate risk
reduction.
The essential idea in the approach of Vickers et al. (2008) is that
a prediction model is used to estimate a patient’s risk of a particular
disease based on evidence related to risk factors, but that the result
should not then simply be compared with a decision threshold for
the purposes of diagnostic decision making. Vickers et al. suggest
that the use of risk prediction models gives doctors explicit informa-
tion (e.g., the risk of heart attack with or without treatment) to use in
shared decision making with patients. This is a step in the direction of
the patient as decision owner, although if themedical profession’s grasp
of the diagnostic process is as shaky as Sbrojavacca’s (2012) survey
seems to suggest, shared decision making between doctors and patients
may not always be straightforward. And indeed, a recent report from
a health literacy workshop led by the Royal College of General Practi-
tioners (Rowlands et al. 2014) mentions that “Written health literature
and doctors’ spoken communication are often not pitched at a level that
is inclusive of people with low health literacy.” While that specific
problem is far beyond the scope of the present article, it does serve,
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at the outset, to emphasize the need for effective communication among
all those involved in a decision process.
In his informal survey, Sbrojavacca (2012) asked doctors participat-
ing in training courses to provide—in a strictly anonymous fashion—a
briefly written, operative description of diagnosis.We repeated this ex-
ercise for various groups of agriculturalists with an interest in crop pro-
tection, obtaining a total number of responses similar to Sbrojavacca’s
study. Each group was surveyed separately and was unaware of the
other groups’ responses. The results are shown in Figure 1. In present-
ing “word clouds” based on each group’s responses, we hope that in-
terested readers are stimulated to consider and evaluate their own
personal response. Our initial impressions of the survey responses
are as follows:
c In terms of evidence from the crop in question, the survey responses
mention a range of signs (indications of disease from direct ob-
servation of a pathogen: microscopy, DNA, PCR) and symptoms
(indications of disease by reaction of the host: visible symptoms,
lesions, damage, poor growth, leaf senescence). Other sources
of evidence include current host data (crop, variety, growth
stage), current environment data (area, site, soil conditions, season,
weather), and some forecast data (weather forecast, yield loss).
c There is an overwhelming emphasis on obtaining objective
evidence—data—as compared with subjective perceptions. But in-
formation may also be sought in the form of advice (agronomist,
consult, expert opinion, confirmation, College).
c The methodology of evidence gathering receives attention, in-
cluding both evidence gathered directly from a crop (crop walk-
ing, field walking, look, observation, inspection, identification,
assessment, description, sample, quadrat), and evidence gath-
ered from other sources (literature, reference, internet, disease
guide).
c There is a place for information in the form of historical data
(previous history, previous problems, previous cropping, previous
diseases, previous weather).
c Our overall impression is that crop protection decision making is
viewed by respondents as a problem.Diagnosis, which depends on
the collection and assessment of evidence and information, is the
corresponding problem-solving process.
But how does that problem-solving process work? Sackett et al.
(1996), among the pioneers of modern evidence-based medicine,
wrote, “it’s about integrating individual clinical expertise and the
best external evidence.” Replace clinical with crop protection, and
there is a basis to begin thinking about evidence-based crop protec-
tion. Reviewing the survey responses, but this time looking at diag-
nostic decision making through the lens of evidence-based crop
protection, there is clearly a substantial appeal both to expertise
and to external evidence. How may they be integrated?
Croskerry (2012) describes two pathways of diagnostic decision
making, the intuitive (informal, subjective, context dependent, qual-
itative, dynamic, flexible) and the rational (formal, objective, scien-
tific, quantitative, verifiable, rigorous). Integration of expertise and
external evidence via the rational pathway leads to decision making
that is less vulnerable to bias. Croskerry and Nimmo (2011) identify
familiarity with the rules of probability and basic Bayesian probabil-
ity theory among de-biasing strategies to reduce diagnostic error.
Sbrojavacca (2012) writes “Whether or not we like it, we behave,
even unconsciously, like convinced Bayesians except that often we
do not know how to draw the proper conclusions.” That is to say,
while decision makers recognize the need for integration of expertise
and evidence in the diagnostic process, still they are prone to use the
intuitive path rather than the rational path (Box 1).
It is interesting to note that none of Sbrojavacca’s (2012) survey
respondents mentioned any probability-based criteria in their
descriptions of diagnosis. The same is true for our survey; many
of the responses relate to adverse consequences, but not in probabi-
listic terms. There is no explicit mention of disease risk.
Now, thinking of crop protection decision making as a process in-
volving the integration of expertise and evidence relating to disease
risk, important epidemiological questions are:
c Where to start? (What is the initial disease risk?)
c What evidence to collect? (What are the relevant risk factors?)
c How to combine initial disease risk with evidence from relevant
risk factors?
c How may the combined evidence lead to a decision?
In addition, we acknowledge that the farm-scale crop protection
decision process is set in a wider societal context in which the range
of responses to disease risk that are available to a decision owner may
be subject to a variety of voluntary and/or legislative constraints. But
first, in order to make an integrated assessment of evidence related to
Fig. 1. Responses to an informal survey requesting a brief operative description of
diagnosis from different groups of agriculturalists with an interest in crop protection,
presented as “word clouds.” The size of a word in the visualization is proportional to
the number of times the word appears in the corresponding input text. The order of
presentation (A, B, C) of the visualizations reflects the order in which the groups were
surveyed, but groups were unaware of other groups’ responses. The visualizations
were prepared using Wordle (Jonathan Feinberg 2013, http://www.wordle.net/). A, A
mixed group of trainee agronomists and farmers (sample size = 14) studying for the
BASIS Certificate in Crop Protection (http://www.basis-reg.com/examsandtraining/
courses.aspx?id=1. B, A meeting of the UK Plant Diagnosticians (UKPD) group, an
informal network of scientists who run plant diagnostic clinics (sample size = 12). C,
A class of Year 2 Agriculture students from SRUC (data set courtesy Dr. Graham
McGrann, sample size = 18) (http://www.sruc.ac.uk/info/120409/agriculture).
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disease risk at the farm scale, we adopt Bayes’ rule as a principled
method by means of which we may address the epidemiological
questions above within a coherent framework (Box 2).
Essentially, in a diagnostic decision process, Bayes’ rule provides
a basis for updating the initial risk with evidence from risk factors
relevant to the process. The application of Bayes’ rule thus centers
on the determination of the probability of need for a control interven-
tion before (the prior probability) and after (the posterior probability)
diagnosis. Madden (2006) calculates a detailed example from phyto-
pathological data, and provides a technical glossary. For ease of cross
reference, we adopt the same notation here.
Initial Disease Risk
The straightforward epidemiological approach is to adopt the ep-
idemic prevalence of a disease in the population in question as the
initial estimate of disease risk (i.e., the prior probability of need
for a control intervention). However, this does not necessarily re-
solve the issue in relation to a particular decision problem. What is
the appropriate population? Is enough known about the disease in
question in that population to be able to assign a value to prevalence?
Note that Bayes’ rule does not tell us where the prior probability
comes from, nor what the appropriate value is. These issues concern-
ing specification of the prior have given rise to a great deal of discus-
sion among statisticians, but it is not our purpose here to contribute to
that debate.
Instead, let us assume that, after appropriate reflection, the popu-
lation of interest can be identified (clearly, this is an issue requiring
epidemiological expertise). Then the prior probability represents
prior information about that population. If there is enough informa-
tion to indicate with some level of certainty that the initial disease risk
is low, then a low prior probability is appropriate. Similarly, if there is
enough information to indicate with some level of certainty that the
initial disease risk is high, then a high prior probability is appropriate.
Intermediate prior probabilities reflect greater uncertainty (less infor-
mation) relating to initial disease risk, with a prior probability of
0.5 representing maximum uncertainty. So information relating to
epidemic prevalence will be reflected in the prior probability adopted
as an initial estimate of risk for a population, and different priors re-
flect different levels of information. If the aspiration is evidence-based
decision making, the goal should be that different participants in a de-
cision process considering the same prior information should assign
the same prior probability. It is in circumstances where the initial es-
timate of risk reflects a high level of uncertainty that there is most to
gain from evidence-based decision making.
For application of Bayes’ rule, some formatting of epidemiologi-
cal quantities is required. The initial estimate of disease risk is
denoted Prob(E+); i.e., the prior probability of the need for a control
intervention. The corresponding prior probability of no need for
a control intervention is denoted Prob(E−) such that Prob(E+) +
Prob(E−) = 1. The prior odds of need for a control intervention is
specified: odds(E+) = Prob(E+)/[1−Prob(E+)]. Similarly, if required,
the prior odds of no need for a control intervention is: odds(E−) =
Prob(E−)/[1−Prob(E−)] = 1/odds(E+). Then log[odds(E+)] and
log[odds(E−)] may be calculated (the base of the logarithm can be
chosen to suit the application; here, we use base-10 logarithms
throughout).
Note that assigning a population value for the prior probability
means that the circumstances relating to crop protection decision
making for an individual crop based on the farmer’s previous expe-
rience still remain to be taken into account in the decision process.
Selecting Risk Factors
A risk factor is a variable that serves as a predictor of the need for
disease control intervention. Risk factors are thus the basis of diag-
nostic tests. Diagnostic tests based on risk factors are used to make
predictions of the need for a control intervention in order to be able to
make control interventions that are preventive. As in the clinical sit-
uation, the application of diagnostic decision thresholds plays an im-
portant part in this strategy (Box 3).
In their pioneering analysis, Stern et al. (1959) defined the eco-
nomic threshold as the population density at which control measures
should be used to prevent an increasing pest population from
Box 1. The intuitive statistician
This is a well-known example (see, e.g., Peterson and Beach 1967); but if you have not previously encountered it, try providing an
answer here via your intuitive pathway (the answer calculated via the rational pathway will be given later). Two urns are each filled with
a large number of colored balls. You know that one urn contains 70% red balls and 30% blue balls, and the other contains 70% blue balls
and 30% red balls. One of the urns is then selected, but you do not know which. The selection was made on the basis of a fair toss of a fair
coin (the outcome of which was hidden from you), so you may reasonably start by taking the probability of each urn being selected as
equal to 0.5. To obtain evidence relevant to identification of the selected urn, you take a sample of balls from it (in such a way that you
cannot select on the basis of color) as follows. The balls in the urn are thoroughly mixed and one ball randomly taken. Its color is then
observed and recorded, and the ball replaced in the urn. The procedure is then repeated; after mixing, another ball is taken, observed,
recorded and replaced. A sample comprising 8 red and 4 blue balls eventually results. What is the probability that the urn with mainly red
balls was the one selected?
Box 2. Bayes’ rule
We know from the monument in Bunhill Fields burial ground in central London that the Reverend Thomas Bayes FRS died on 7 April
1761 aged 59. So the year of Bayes’ birth must have been 1701 or 1702; but at the time of writing the official record has still not been
located. The work that describes what we refer to here asBayes’ rulewas published posthumously, in 1764. An excellent narrative history
of Bayes’ work and its modern applications is now available (McGrayne 2011). In the present context, McGrayne’s Chapter 4, Bayes goes
to war, is where we begin. The use of Bayes’ rule by Alan Turing and colleagues in their work on cryptography at Bletchley Park during
World War II (Good 1979) began a renaissance for statistical applications of Bayesian methods in decision theory. In Bayes’ rule, the
codebreakers had amathematical framework for analysis of probabilities that allowed quantification of the weight of evidence provided by
individual clues in the available data, and a method of updating this quantity as further clues were revealed. Working in terms of loga-
rithms meant that the updating of evidence was an additive process (Turing and colleagues used base-10 logarithms). Then, a prespe-
cified decision rule was used to determine whether the evidence was sufficient to allow a judgment to be made. Much more recently, Van
den Ende et al. (2007) adopted this approach in the context of diagnostic clinical epidemiology, presenting a diagrammatic approach to
evidence accumulation that provides a useful visual representation of the Bayesian updating process (again using base-10 logarithms). A
version of this diagrammatic approach could have application in crop protection decision making, where there is a natural time sequence of
risk accumulation over the growing season.
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reaching the economic injury level. The economic injury level is the
lowest population density that will cause an amount of crop injury
that justifies the cost of artificial control measures. This scheme rec-
ognizes that it is not a practical proposition to wait until a pest pop-
ulation reaches the economic injury level before taking action, and
therefore that control measures should be taken in response to the threat
of pest injury. Stern et al. were primarily concerned with the integrated
control of arthropod pests, and in its original formulation, the economic
threshold was denominated in units of pest population density. The
range of crop protection problems under consideration here may in-
volve a wider range of risk factors. In selecting a set of risk factors rel-
evant to a particular crop protection decision process, a common-sense
desire is to avoid possible double counting of evidence. In a diagnostic
process based on several risk factors, Bayes’ rule does not help us to
identify risk factors, nor (at least in its simplest form of application)
account for conditional dependence between them.
Identification and quantification of risk factors requires epidemio-
logical expertise. Measures can be taken to counter the impact of con-
ditional dependence, including careful selection of likely risk factors
(remembering that the more that are used, the more that conditional
dependence is likely to be a problem), and statistical assessment of de-
pendence among factors. In cases where more than one risk factor is
assessed during the course of diagnostic decision making, it is impor-
tant is that the different sources of evidence can be assessed using
a common currency. This is where Bayes’ rule has its application.
Evidence Accumulation
We are concerned here with binary diagnostic tests. The basis for
such a test is provided by placing a threshold on the measurement
scale of a risk factor, such that crops that are scored above the thresh-
old are predicted epidemics (requiring treatment, i.e., application of
an appropriate product at an appropriate dose rate) and crops that are
scored at or below the threshold are predicted non-epidemics (not re-
quiring treatment). Note that risk factors are usually calibrated so that
higher values correspond to greater need for intervention.
However, diagnostic tests, since they embody predictions, are im-
perfect. As described in Madden (2006), desirable properties for
a good test are for Prob(P+|E+), the probability of a correct prediction
of need for treatment, to be high (i.e., close to 1) and Prob(P+|E−),
the probability of an incorrect prediction of need for treatment
when there turns out to be no need for treatment, to be low
(i.e., close to 0). These conditional probabilities are properties of
a diagnostic test, estimated from data by, respectively, the propor-
tion of epidemics correctly predicted (called the true positive pro-
portion, abbreviated TPP, sometimes referred to as sensitivity) and
the proportion of non-epidemics incorrectly predicted to be epi-
demics (called the false positive proportion, FPP). Similarly, for
a good test, it is desirable for Prob(P−|E−), the probability of a cor-
rect prediction of no need for treatment, to be high (i.e., close to 1)
and Prob(P−|E+), the probability of an incorrect prediction of no
need for treatment when there turns out to be a need for treatment,
to be low (i.e., close to 0). These conditional probabilities are es-
timated, respectively, by the proportion of non-epidemics correctly
predicted (called the true negative proportion TNP, sometimes re-
ferred to as specificity) and the proportion of epidemics incorrectly
predicted to be non-epidemics (called the false negative propor-
tion FNP).
A binary diagnostic test based on a particular risk factor can be
characterized by the likelihood ratio of a positive prediction (i.e., a
prediction of an epidemic): LR(+) = TPP/FPP, and the likelihood
ratio of a negative prediction (i.e., a prediction of a non-epidemic):
LR(−) = FNP/TNP (e.g., Madden 2006). The likelihood ratio
of a positive prediction tells us the extent to which a prediction
of an epidemic (a positive result on the diagnostic test) is likely
to come from an actual epidemic as compared with an actual
non-epidemic (LR(+) should be a positive number greater than 1,
the larger the value the better). The likelihood ratio of a negative
prediction tells us the extent to which a prediction of a non-
epidemic (a negative result on the test) is likely to come from an
actual epidemic as compared with an actual non-epidemic (LR(−)
Box 3. Risk factors
The term risk factor originates with the systematic identification and quantification of behaviors (e.g., smoking) and biomarkers (e.g.,
cholesterol) associated with future coronary disease in The Framingham Study (Kannel et al. 1961). In the plant pathology literature an
early use appears in Zadoks and Schein (1979), where the index includes a reference to factors increasing risk. The identification and
quantification of disease risk factors has now become fundamental to modern epidemiology. In the context of decision making for crop
protection, a useful way of thinking about risk factors relates to the generic disease triangle (D’Arcy et al. 2001), a diagram that shows the
three important components necessary for disease: a susceptible host, a virulent pathogen, and a favorable environment. Risk factors
are the particular host, pathogen, and environmental factors that increase disease risk in a given plant pathosystem. The generic disease
triangle becomes a specific risk triangle.
Box 4. The rational statistician
Now we can return to the urn problem as set out previously for the intuitive statistician. Here, taking a Bayesian perspective, the
objective is to calculate the probability that the urn with mainly red balls was the one selected, given the evidence from the sample. Under
the conditions of the problem, the prior probability that the urn with mainly red balls was selected is equal to 0.5. Thus the prior odds is
equal to 1 and the prior log-odds is zero. This is consistent with the situation in which you have no prior information that leads you toward
a decision in favor of one urn or the other; at the outset, you aremaximally uncertain. On the hypothesis is that the urn with mainly red balls
was the one selected, TPP (the proportion of red balls in the urn with mainly red balls) = 0.7, FPP (the proportion of red balls in the urn with
mainly blue balls) = 0.3, LR(+) = 2.333 and log[LR(+)] = 0.368. Also, FNP (the proportion of blue balls in the urn with mainly red balls) = 0.3,
TNP (the proportion of blue balls in the urn with mainly blue balls) = 0.7, LR(−) = 0.429, and log[LR(−)] = −0.368. So the accumulated
weight of evidence from the sample of 8 red balls and 4 blue balls is equal to 8 × 0.368 + 4 × (−0.368) = 4 × 0.368 = 1.472. Then the
posterior log-odds in favor of the urn with mainly red balls being the one selected, given the evidence, is equal to the prior log-odds plus
the weight of evidence: 0 + 1.472 = 1.472. To express this as a probability, first calculate the inverse log, 101.472 = 29.641; then the pos-
terior probability that the urn with mainly red balls was selected, given the evidence, is equal to 29.641/(1 + 29.641) = 0.967. Peterson and
Beach (1967) comment that most subjects who try this example typically provide an intuitive posterior probability of about 0.75, which is
very conservative compared with the Bayesian posterior probability of 0.967. There is another way to look at this. The calculated posterior
odds30; but an intuitive posterior probability of 0.75 corresponds to an intuitive posterior odds of 0.75/(1 − 0.75) = 3, an order of magnitude
smaller than the calculated value. Thus the example provides a simple illustration of the potential for bias on the intuitive decision path,
because the intuitive decision path provides an unreliable assessment of the evidence.
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should be a positive number less than 1, the smaller the value the
better).
On taking logarithms, the resulting log[LR(+)] and log[LR(−)]
are additive factors that describe the amount of evidence provided
by the results of an imperfect binary diagnostic test. I. J. Good,
who wrote extensively on Bayes’ rule (after working with Turing
during World War II on the analysis of the German naval cipher
system) termed log[LR(+)] and log[LR(−)] weights of evidence.
In the discussion of Good (1985), the following exchange is
recorded:
“In short, my question to Professor Good is this one. What
shall I do with weight of evidence?”
“My answer is that the weight of evidence… should be added
to the initial log-odds … to obtain the final log-odds.”
Good’s response is a statement of Bayes’ rule, sometimes referred
to as the evidence form of the rule. Stating Bayes’ rule in this form
provides, in essence, a bookkeeping procedure that allows us to keep
track of evidence accumulation based on data relating to risk factors,
by calculation of corresponding log-likelihood ratios (Box 4).
Among the desirable properties of log-likelihood ratios for evi-
dence accumulation, we note the following.
c Log-likelihood ratios are independent of the prior probability;
log[LR(+)] and log[LR(−)] are properties of a diagnostic test based
on a particular risk factor.
c Log-likelihood ratios quantify evidence provided by the outcomes
of diagnostic tests.
c Log-likelihood ratios provide a common currency for evidence
accumulation. This is important because it allows us to accumulate
evidence toward diagnostic decision-making using risk factors for
which data may be recorded on different measurement scales. The
unit of the common currency depends on the base of the logarithm
used in calculation.
c Log-likelihood ratios are additive for a diagnostic process based
on a series of risk factors (note that log-likelihood ratios are not
probabilities, and that evidence is not accumulated additively on
a probability scale).
c Expressing log-likelihood ratios as weights of evidence provides
a terminology in which technical usage matches the everyday
language interpretation.
Reaching a Decision
Essentially what Bayes’ rule provides is a formal structure for the
problem of diagnostic decision making. The application of Bayes’
rule enables the combination of an initial estimate of disease risk
based on prior information with evidence related to disease risk in
a current crop. It allows evidence from different kinds of risk factors,
on different measurement scales, to be combined; leading to a risk
prediction, the posterior probability of need for intervention given
the evidence. Returning to Sbrojavacca (2012), where we started,
he writes: “What counts is that we are aware that the diagnostic pro-
cess is based upon probability and not certainty, that we are prone to
biases, those diagnostic tests can have false positives and false neg-
atives, that having reached a certain threshold of probability and
trust in diagnosis we should decide, with our patients, what to do
or not do.”
Fig. 2. Eyespot disease of wheat. A, Eyespot lesion on the stem base of wheat. B and
C, Eyespot fungicide efficacy trials are part of the experimental program underpinning
the new disease risk assessment. Trial plots are shown in the spring before
assessment relating to the eyespot fungicide treatment decision (B) and later in
the season after the treatment decision (C).
Box 5. The Fungicide Resistance Action Group UK (FRAG-UK)
FRAG-UK is a group of independent scientists and experts in fungicide resistance (Burnett 2011). It includes policy makers and
representatives from industry, and produces messages on predicted resistance risk and on effective strategies to manage resistance
risk. Farmers in the UK have lived with fungicide resistance issues almost since the introduction of fungicides to the UK market.
FRAG-UK was established in response to these early resistance issues in order to bring together the collective experience of research-
ers, practitioners, and industry in an independent forum concentrating on issues affecting the UK. Farmers’ attitudes to fungicide resis-
tance have changed over the years, but it remains a challenge to promote resistance management strategies in a market that would put
immediate crop yield and profit above product stewardship. Motivation to modify treatment preferences in order to improve stewardship
and address the risk of resistance development requires clear messages about effective resistance management practices that are cog-
nizant of the practical limitations of actual farming practice.
http://www.pesticides.gov.uk/guidance/industries/pesticides/advisory-groups/Resistance-Action-Groups/frag
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Thus the Bayesian diagnostic process provides a rational path
through probabilities and biases to a place where accumulated evi-
dence is the basis for shared decision making. Shared decision mak-
ing, as advocated by Vickers et al. (2008), might at first appear to
have abandoned decision thresholds. But in the article’s ensuing cor-
respondence the point is made that regardless of whether binary di-
agnostic approach or a risk prediction approach is adopted, treatment
of a patient still involves a threshold. The difference is that risk pre-
diction allows the choice of operational threshold to be modified for
the individual subject. Thus the risk prediction approach allows in-
dividual perceptions of risk to be taken into account, and therefore
the patient’s attitude to risk. The treatment of a patient still involves
a binary decision, but the decision threshold has been individualized.
From a crop protection perspective, an example of a risk predic-
tion approach is the management of eyespot disease of wheat (caused
byOculimacula yallundae and/orO. acuformis). In the United King-
dom, this is the most common and most damaging of the complex of
diseases that infect the stem base (Fig. 2). A new risk assessment
method—underpinned by continued fungicide efficacy trials—includes
an early assessment of agronomic risks followed by a disease assess-
ment carried out in Spring (GS30–31) to judge the need for fungicide
application (Burnett and Hughes 2014). This enables farmers to iden-
tify individual fields at greater disease risk, allowing an integrated
management approach through cultural control measures, such as
the use of eyespot-resistant varieties and delayed sowing. This kind
of risk prediction approach is consistent with a new study by Sherman
and Gent (2014), who noted that: “Respect for farmers’ knowledge
and experiences, recognition of their situation-dependent constraints
and goals, and responsiveness to their individualized needs” were
valued factors contributing to decision making by farmers. However,
farmers’ individualized crop protection needs are part of a bigger
picture.
The Bigger Picture: Collective Risk
In the clinical situation, for a risk-averse patient, effective treat-
ment is a risk-reducing strategy since it prevents the undesirable out-
come of foregoing treatment in the sick state (Felder and Mayrhofer
2014). But if the patient population is overwhelmingly risk averse,
this can have consequences; for example, meeting widespread patient
demand for antibiotics is at odds with strategies to limit increasing
antibiotic resistance (Hawker et al. 2014). In farm-scale crop protec-
tion decision making, farmers, as decision owners, face similar
issues. Crop protection decisions made on the basis of short-term dis-
ease risk at the level of the individual crop also have implications for
long-term collective risk, for example in terms of fungicide resistance
management. Indeed, there are notable similarities in the strategies
for the management of fungicide and antibiotic resistance (van den
Bosch and Gilligan 2008).
Control of fungal plant pathogens has been characterized by intro-
duction of new fungicides and subsequent loss of efficacy with the
emergence and selection of resistant pathogen genotypes (van den
Bosch et al. 2011). Typically, farmers with crops to protect are risk
averse, especially in the case of high-value intensive crops (Gent
et al. 2011; Shtienberg 2013). In this context, the survey responses
of grape growers in Oregon and Washington noted by Gent et al.
(2013) are of particular interest. In a list of management considera-
tions rated as “extremely important,” controlling pesticide resistance
ranked third, behind only preventing major pest and disease out-
breaks and treating diseases in early stages. The issue then becomes
one of managing actions in order to balance short-term individual
risk and long-term collective risk.
Typically, decision making in crop protection depends on attitudes
to risk and crop economics at the farm scale ahead of concerns about
product stewardship. Farmers, post-diagnosis, may be able to select
from a range of fungicides in a variety of tank mixtures, alternations,
application timings, doses, and application equipment and technolo-
gies. If short-term predictions of economic gain are weighed against
long-term predictions of the development of fungicide resistance, the
impact of individual behavior may seem negligible when compared
with the collective behavior of the population. Here, there is an
important role for trusted independent sources of evidence; in the
UK, the Fungicide Resistance Action Group UK (FRAG-UK) is
one such (Box 5).
Voluntary stewardship will always be somewhat variable in imple-
mentation, so legislative restrictions may also be useful provided
they are evidence based and do not overly limit productivity. For ex-
ample, in the European Union, limitations on the permitted number
of seasonal fungicide applications for products having a particular
mode of action are often included in statutory advice on product
labels and enforced through farm inspections, with breaches penal-
ized through the system of Single Farm Payments. FRAG-UK has
a role here in identifying those situations where resistance risks
are of sufficient severity to merit such restrictions on use, and those
where, on balance, voluntary stewardship would suffice. This kind of
judgement of existing evidence is essential in an area where industry
and regulatory decisions about fungicide resistance management are
made in a dynamic farming sector (van den Bosch et al. 2014).
In Conclusion
A characteristic of agricultural policy problems is that govern-
ments, or other policy-making bodies, have only a limited set of var-
iables under their direct control (Candler et al. 1981). At the policy
scale, an issue for fungicide resistance management research is to
provide farmers with the evidence base for operational integration
of short-term crop protection decision making and longer-term stew-
ardship measures. Further studies of farmers’ risk perceptions and
decision preferences in crop protection decision making can only
help in the establishment of successful and sustainable programs that
incorporate policy issues aimed beyond the farm scale. But it remains
the case that measuring risk perceptions and decision preferences in
a way that captures the effectiveness of an evidence-based approach
to crop protection is problematic.
In the UK, some doctors have adopted patient reported outcome
measures (PROMs) as a tool for eliciting patients’ perceptions of
the effectiveness of care (Black 2013). PROMs were initially devel-
oped for use in research, for assessing and comparing the outcomes
achieved by healthcare providers, but the methodology can also serve
to provide a database that has potential to help patients and doctors
make better (shared) decisions. However, reading the views
expressed in the published responses to Black’s article only serves
to emphasize the difficulties involved: for example, how can the
same database both inform individual care and satisfy the require-
ments of audit, how can “more protocols, red tape, targets and dig-
ital philosophy” be justified in primary care, and how can PROMs do
other than “stoke the fires of bureaucracy”?
The fact remains that while the effectiveness of shared decision
making in an agricultural (or, as we have just seen, a clinical) setting
may be extremely difficult to assess, finding ways to do so is a prior-
ity. And not just for research purposes, but because—as illustrated so
well by Sherman and Gent (2014)—the quality of decision making
depends ultimately on effective knowledge exchange among all
those involved in a decision process. The integration of experience,
evidence, and expertise is an aspiration that drives participatory
approaches to the management of plant disease.
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